1. Home
  2. ZLAB vs LSPD Comparison

ZLAB vs LSPD Comparison

Compare ZLAB & LSPD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ZLAB
  • LSPD
  • Stock Information
  • Founded
  • ZLAB 2013
  • LSPD 2005
  • Country
  • ZLAB China
  • LSPD Canada
  • Employees
  • ZLAB N/A
  • LSPD N/A
  • Industry
  • ZLAB Biotechnology: Pharmaceutical Preparations
  • LSPD
  • Sector
  • ZLAB Health Care
  • LSPD
  • Exchange
  • ZLAB Nasdaq
  • LSPD Nasdaq
  • Market Cap
  • ZLAB 3.6B
  • LSPD 1.6B
  • IPO Year
  • ZLAB 2017
  • LSPD 2020
  • Fundamental
  • Price
  • ZLAB $35.19
  • LSPD $11.88
  • Analyst Decision
  • ZLAB Buy
  • LSPD Buy
  • Analyst Count
  • ZLAB 5
  • LSPD 13
  • Target Price
  • ZLAB $54.28
  • LSPD $13.42
  • AVG Volume (30 Days)
  • ZLAB 689.4K
  • LSPD 499.0K
  • Earning Date
  • ZLAB 08-07-2025
  • LSPD 07-31-2025
  • Dividend Yield
  • ZLAB N/A
  • LSPD N/A
  • EPS Growth
  • ZLAB N/A
  • LSPD N/A
  • EPS
  • ZLAB N/A
  • LSPD N/A
  • Revenue
  • ZLAB $418,326,000.00
  • LSPD $1,076,826,000.00
  • Revenue This Year
  • ZLAB $44.07
  • LSPD $13.02
  • Revenue Next Year
  • ZLAB $49.13
  • LSPD $16.19
  • P/E Ratio
  • ZLAB N/A
  • LSPD N/A
  • Revenue Growth
  • ZLAB 43.72
  • LSPD 18.43
  • 52 Week Low
  • ZLAB $16.01
  • LSPD $7.34
  • 52 Week High
  • ZLAB $44.34
  • LSPD $18.96
  • Technical
  • Relative Strength Index (RSI)
  • ZLAB 49.90
  • LSPD 56.95
  • Support Level
  • ZLAB $32.31
  • LSPD $11.37
  • Resistance Level
  • ZLAB $35.72
  • LSPD $11.92
  • Average True Range (ATR)
  • ZLAB 1.10
  • LSPD 0.29
  • MACD
  • ZLAB -0.34
  • LSPD -0.03
  • Stochastic Oscillator
  • ZLAB 60.17
  • LSPD 84.18

About ZLAB Zai Lab Limited

Zai Lab Ltd is a biopharmaceutical company focusing on discovering or licensing, developing, and commercializing proprietary therapeutics that address areas of unmet medical need including in the fields of oncology, autoimmune and infectious diseases. The pipeline of proprietary drug candidates of the company includes ZL-1218 (CCR8) Solid Tumors, ZL-1310 (DLL3 ADC) ES-SCLC Other NECs, ZL-6301 (ROR1 ADC) Solid Tumors, ZL 6201 (LRRC15 ADC) Solid Tumors.

About LSPD Lightspeed Commerce Inc. Subordinate Voting Shares

Lightspeed Commerce Inc provides an omni-channel commerce-enabling SaaS platform. Its software platform provides customers with the functionality it needs to engage with consumers, manage their operations, accept payments, and grow their businesses. The company sells its platform through a direct sales force in the United States, Canada, United Kingdom, Australia, and other countries. It derives a majority of its revenue from the United States.

Share on Social Networks: